An Analysis of Kinesio® Tape on Myofascial Pain Syndrome of the Iliotibial

Status Completed

Clinical Trial Summary

Participants will report for two research sessions. Prior to arrival, membership to a club sports team will be confirmed via email. The first session will require one hour, while the second will require 30 minutes. Maximum amount of time expected is one and a half hours, over two sessions in 48 hours. The 1st and 2nd sessions will be separated by 48 hours. Upon arrival for session 1, informed consent will be obtained along with the following demographic information: age, sex, height, weight, dominant leg, and sport. Next, the participant will complete the Musculoskeletal Questionnaire (MQ) in regard to the last 12 months. Participants will then be assessed for trigger points in their dominant side iliotibial band via palpation. Diagnostic criteria for trigger point will be modeled after Travell and Simons: taut band, pain upon palpation, referred pain, and a local twitch response. Up to four trigger points will be marked on the subject's skin with marker or pen. Pain pressure threshold will be obtained via algometer, using the terminology "Tell me the first moment you experience pain by verbalizing 'pain' ". Then, three pain pressure threshold readings will be taken per trigger point and then averaged by the researcher. Kinesiology tape will then be applied to the identified trigger points using the Fascial Technique. Pain pressure threshold will be obtained again with the same protocols 10 minutes after the tape is applied. The participant will be asked to wear the tape for 48 hours. Upon arrival for session 2, the application of the tape will be confirmed. With the participant's choice to continue in the study, a third and fourth measurement of pain pressure threshold will be obtained: one with the tape remaining on, and another 10 minutes after removal of the tape. Again, three pain pressure threshold readings will be taken per trigger point and then averaged by the researcher.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04531306
Study type	Interventional
Source	North Dakota State University
Contact
Status	Completed
Phase	N/A
Start date	October 4, 2020
Completion date	November 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06029413` - Myo vs. Myofascial Injection for Myofascial Trigger Points	N/A
Recruiting	`NCT04985578` - Effects on Muscle Activity After Dry Needling in Myofascial Trigger Points of the Gastrocnemius Muscles	N/A
Completed	`NCT05546203` - Trigger Point Treatment in Chronic Pelvic Pain	N/A
Completed	`NCT06258070` - Clinical Performance of Therapeutic Use of BTX for Bruxism	N/A
Completed	`NCT03708107` - Percutaneous Microelectrolysis (MEP) Versus Ischemic Compression in Miofascial Trigger Points	N/A
Completed	`NCT02913976` - Changes on Pain and Range of Motion by the Use of Kinesio Taping in Patients Diagnosed With Cervical Pain	N/A
Completed	`NCT02913963` - Changes on Pain and Range of Motion by the Use of Kinesio Taping in Subjects With Myofascial Trigger Point	N/A
Completed	`NCT04719689` - Comparison of Dry Needling and Dry Cupping in Positional Fault of Pelvis	N/A
Recruiting	`NCT05792111` - Caudal Epidural Steroid and Trigger Point Injection	Phase 4
Completed	`NCT03704311` - Evaluation of Mitochondrial Function in Myofascial Trigger Points Cohort Pilot Study Using High-resolution Respirometry	N/A
Recruiting	`NCT05429827` - The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome	N/A
Recruiting	`NCT05151510` - Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department	Phase 4
Completed	`NCT05396196` - An Analysis of Kinesio® Tape With Manual Fascial Glide Application on Trigger Points in The Iliotibial Band	N/A
Completed	`NCT05664165` - The Efficiency of Dry Needling and Cold Spray-stretching Treatments	N/A
Completed	`NCT01250184` - Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.	Phase 4
Enrolling by invitation	`NCT03941054` - Myosfascial Trigger-Points and Effects on Neuromuscular Response	N/A
Completed	`NCT04993118` - Integration of Neuromuscular Inhibition Technique On Trapezius Trigger Points.	N/A
Completed	`NCT04851743` - Effects on Neuromuscular Function After Dry Needling in Myofascial Trigger Points in the Gastrocnemius Muscles	N/A
Not yet recruiting	`NCT06338514` - The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.	N/A
Recruiting	`NCT06013644` - Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

An Analysis of Kinesio® Tape on Myofascial Pain Syndrome of the Iliotibial Band

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms